Skip to main content
editorial
. 2010 Jun 7;16(21):2579–2588. doi: 10.3748/wjg.v16.i21.2579

Figure 2.

Figure 2

Daily amount of soft drinks consumption in nonalcoholic fatty liver disease (NAFLD) patients with (n = 31) or without metabolic syndrome (n = 29) and in controls (n = 30). aP < 0.07; fatty liver without metabolic syndrome vs fatty liver with metabolic syndrome, bP < 0.001 between fatty liver subgroups and controls[14,15].